- Advertising
- Asia
- Bangladesh
- Biological Inventions
- BRAND VALUATION
- China
- Comparative Advertisement
- Copyright
- Copyright Infringement
- Copyright Litigation
- Counterfeiting
- Covid
- Design
- Digital Marketing Rights
- DRM
- Geographical Indication
- India
- Indian Patents Act
- Indonesia
- Intellectual Property
- Interim Injunction
- IP Commercialization
- IP Licensing
- IP Litigation
- IP Practice in India
- IPAB
- IPAB Decisions
- Japan
- Legal Issues
- Licensing
- Malaysia
- Myanmar
- NCLT
- NEPAL
- Net Neutrality
- News & Updates
- Office
- Patent Commercialisation
- Patent Cooperation Treaty
- patent infringement
- Patent Licensing
- Patent Litigation
- Patent Opposition
- Patent Prosecution
- Patent Rule Amendment
- Patent Term Extension
- Patents
- pharma
- Philippines
- Punitive Damages
- Section 3(D)
- section 64
- Singapore
- South-east Asia
- Technology
- Technology Transfer
- Thailand
- Trademark
- Trademark Litigation
- Uncategorized
- USPTO
- Vietnam
- WIPO
Technology Transfer/Licensing Opportunity of Crop/Agri Technologies with Syngenta
IIPRD is among the leading Indian IP Consulting Firms focusing on Technology Transfer and Licensing for numerous Indian and Global Corporates and Research Institutes. IIPRD is highly active in the Technology Transfer and Licensing of Patent Backed Technologies/IP’s in the domains of Pharmaceutical, Life Sciences, Diagnostics, Biotechnology, Telecommunications, Software, and Medical Devices among others. Syngenta … Continue reading Technology Transfer/Licensing Opportunity of Crop/Agri Technologies with Syngenta
Read more »Natco Files India’s First Compulsory Licensing Application
September 14, 2011 - 4:38 am
Categories:
Patent Commercialisation
Pharma- biotech- Patent Commercialisation
0 Comments
Natco Pharma has filed India’s first Compulsory Licensing (CL) Application (in accordance with Section 84(1) of the Indian Patents Act) against one of the Bayer’s patented drug Sorafenib, marketed by Bayer as Nexavar for treating Kidney and Liver Cancer. Patent on Sorafenib is granted in India on 03.03.2008 having number IN 215758. This will be … Continue reading Natco Files India’s First Compulsory Licensing Application
Read more »Inventors – All Technologies Are not Worth Billions
July 31, 2011 - 6:23 pm
Categories:
high-tech-patent-commercialisation
Patent Commercialisation
Pharma- biotech- Patent Commercialisation
0 Comments
Working in the IP/Technology Commercialization and Out-Licensing domain makes you assess and evaluate the commercial viability of numerous IP backed inventions across technology domains. Apart from learning about and assessing new technologies, we also tend to learn quite a lot about Inventors’ mindset, specifically about their perspective of their own inventions. This article relates to … Continue reading Inventors – All Technologies Are not Worth Billions
Read more »Anti Cancer drug: Making it Patient-driven, not Disease-driven
April 11, 2011 - 10:16 am
Categories:
Patent Commercialisation
Pharma- biotech- Patent Commercialisation
0 Comments
Introduction: French compatriots Ipsen and bioMérieux, have been few most potential companies since 2007 in the development of companion assay to assess patient benefit from a compound useful for treating several severe forms of cancers. The partnership between two companies has focused on the two main broad areas of pharma research: Personalized medicine and Theranostics. … Continue reading Anti Cancer drug: Making it Patient-driven, not Disease-driven
Read more »Food Market making Profit from Climatic Changes
March 14, 2011 - 7:15 am
Categories:
Patent Commercialisation
Pharma- biotech- Patent Commercialisation
0 Comments
Climatic changes being a source of making a profit for food crop manufacturers. Adverse changes in climate have triggered the ecosystems affecting crops, livestock, fisheries and forests, and the billions of people whose livelihoods depend on them. Extreme climate events (especially hotter, drier conditions in semi-arid regions) are likely to slash yields for maize, wheat, … Continue reading Food Market making Profit from Climatic Changes
Read more »Internatioinal Patent Protection in Electronics & IT (SIP – EIT) Scheme by DIT
December 16, 2010 - 7:32 am
Categories:
high-tech-patent-commercialisation
Patent Commercialisation
0 Comments
It is enriching to hear and read so much of focus going these days into Innovation at Grass Root and Startup level. With initiatives being taken at all levels by Stakeholders including FICCI, MSME, DIT, and NASSCOM, the next wave of the so-called Start-up innovation can really be envisioned. As has correctly been stated by … Continue reading Internatioinal Patent Protection in Electronics & IT (SIP – EIT) Scheme by DIT
Read more »Hi-tech Patent Licensing Trends
June 14, 2010 - 12:14 pm
Categories:
high-tech-patent-commercialisation
Patent Commercialisation
0 Comments
Ever since Software Patents have got easier to get a grant for, protection of computer-readable medium claims on a storable media has enforced the Intellectual Property Rights to a much higher level than a software company can have when compared with the counterpart System and Method claims. Although most countries, unlike the US, are still … Continue reading Hi-tech Patent Licensing Trends
Read more »Indian Pharmaceutical Industry Licensing Deals: Case Studies
June 14, 2010 - 10:36 am
Categories:
Patent Commercialisation
Pharma- biotech- Patent Commercialisation
1 Comments
Glenmark Pharmaceuticals Glenmark, research-driven, global, integrated pharmaceutical company with Research Focus on Inflammatory Diseases, Metabolic Disorders and Pain has a presence in over 80 countries around the world. The Company has a proven track record of entering into Licensing deals with Big Pharma and entered into Outlicensing deals in 2004 with Forest laboratories for Oglemilast, … Continue reading Indian Pharmaceutical Industry Licensing Deals: Case Studies
Read more »